FDA Drug Application (022172) for SEROQUEL XR by ASTRAZENECA

Back to FDA Applications sponsored by ASTRAZENECA

Application Number022172
Product Number001
FormTABLET, EXTENDED RELEASE; ORAL
Dosage50MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSEROQUEL XR
Active IngredientQUETIAPINE FUMARATE



Back to FDA Applications sponsored by ASTRAZENECA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.